To investigate the role of macrophages in PBRM1 knockdown‐mediated enhancement of immunotherapeutic effects, we utilized clodronate liposomes to deplete tumor‐infiltrating macrophages and assessed tumor volume and burden. The gene discussed is PBRM1; the disease is neoplasm.